
Nanostics and Protean BioDiagnostics Partner to Launch CDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the United States
In Today’s News: Nanostics Inc. and Protean BioDiagnostics have partnered to launch CDX Prostate in…

In Today’s News: Nanostics Inc. and Protean BioDiagnostics have partnered to launch CDX Prostate in…

In Today’s News: Texas Attorney General (AG) reaches a settlement with a health AI company…

In Today’s News: “Metsera revealed pivotal Phase 1 data proposing a monthly weight-loss medicine, specifically…

In Today’s News: Four health system leaders have been named to Constellation Research’s “Artificial Intelligence…

In Today’s News: The integration of AI into mental healthcare is more advanced than many…

In Today’s News: Kintsugi, a leading innovator in the mental health industry, has been honored…

In Today’s News: AllazoHealth has launched a first-of-its-kind AI-Enabled Dynamic Modular Content solution to aid…

In Today’s News: Hyperautomation company Hyperscience Inc. today announced updates to its Hypercell platform designed…